Results 41 to 50 of about 247,670 (219)

LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p

Cancer Management and Research, 2021
Hong Zeng, Yongqiang Wei, Xiaolei Wei, Ru Feng Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Ru FengDepartment of Hematology, Nanfang Hospital, Southern ...
Zeng H, Wei Y, Wei X, Feng R
doaj  

Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report

BMC Neurology, 2022
Background CD20-negative diffuse large B-cell lymphoma is a very rare and heterogeneous invasive cancer characterized by chemical resistance and poor prognosis.
Shuai Luo, Xiang Huang, Yao Li, Jinjing Wang   +3 more
doaj   +1 more source

Primary diffuse large B-cell lymphoma of the uterus

Medicine, 2021
Uterine diffuse large B-cell lymphoma (DLBCL) is a rare clinical condition. Most studies for uterine DLBCL are derived from case reports and series.
Allyne M. Ensor, C. G. Sanchez, J. Ensor, K. Anand   +3 more
semanticscholar   +1 more source

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead [PDF]

, 2015
Non-Hodgkin lymphoma is the fourth most common malignancy in children, has an even higher incidence in adolescents, and is primarily represented by only a few histologic subtypes. Dramatic progress has been achieved, with survival rates exceeding 80%, in
Auperin, Anne, Brugi\ue8res, Laurence, Burkhardt, Birgit, Cairo, Mitchell S, Damm Welk, Christine, Gross, Thomas G, Horibe, Keizo, Klapper, Wolfram, Lamant, Laurence, Le Deley, Marie C\ue9cile, Macintyre, Elizabeth, Minard Colin, V\ue9ronique, Mussolin, Lara, Patte, Catherine, Perkins, Sherrie L, Pillon, Marta, Poirel, H\ue9l\ue8ne A, Raphael, Martine, Reiter, Alfred, Rosolen, Angelo, Sandlund, John T, Williams, Denise, Woessmann, Wilhelm, Zimmerman, Martin   +23 more
core   +1 more source

Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case report

Journal of Medical Case Reports, 2022
Background Cervical thymoma is a rare thymic epithelial neoplasm. Evidence supports an increased risk of second primary malignancies in patients with thymoma.
Chutima Kunacheewa, Sattawut Wongwiangjunt, Sanya Sukpanichnant   +2 more
doaj   +1 more source

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.

The Lancet Oncology, 2020
BACKGROUND Patients with relapsed or refractory diffuse large B-cell lymphoma who are ineligible for autologous stem-cell transplantation have poor outcomes and few treatment options.
G. Salles, J. Duell, E. González Barca, O. Tournilhac, W. Jurczak, A. Liberati, Z. Nagy, A. Obr, G. Gaidano, M. André, N. Kalakonda, M. Dreyling, J. Weirather, M. Dirnberger-Hertweck, S. Ambarkhane, G. Fingerle-Rowson, K. Maddocks   +16 more
semanticscholar   +1 more source

Mantle cell lymphoma of the larynx: Primary case report [PDF]

, 2012
INTRODUCTION: Primary laryngeal lymphomas are exceedingly rare. Only about a hundred cases have been reported. They consist mainly of non-Hodgkin lymphoma, especially of diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue.
Anass A Bennani-Baiti, Hassan Errihani, Houda Mouzount, Leila Essakali, Meriem Glaoui, Mohamed Kzadri, Samia Ghanem, Sarah Naciri   +7 more
core   +2 more sources

Transplant in Diffuse Large B-Cell Lymphoma

Brazilian Journal of Transplantation, 2022
Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis.
Guilherme Duffles, Carmino De Souza
doaj   +3 more sources

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma

Haematologica, 2011
Background Mediastinal gray zone lymphoma is a newly recognized entity with transitional morphological and immunophenotypic features between the nodular sclerosis subtype of Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma.
Franziska C. Eberle, Jaime Rodriguez-Canales, Lai Wei, Jeffrey C. Hanson, J. Keith Killian, Hong-Wei Sun, Lisa G. Adams, Stephen M. Hewitt, Wyndham H. Wilson, Stefania Pittaluga, Paul S. Meltzer, Louis M. Staudt, Michael R. Emmert-Buck, Elaine S. Jaffe   +13 more
doaj   +1 more source

Post-CAR-T cell therapy presenting as proteinaceous lymphadenopathy

Human Pathology: Case Reports, 2021
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and is often treated with chemotherapy, autologous stem cell transplant, and chimeric antigen receptor (CAR-T) cell therapy.
Mishi Bhushan, Kirthi R. Kumar
doaj   +1 more source